经皮冠状动脉介入治疗-话题@MedSci

#经皮冠状动脉介入治疗#

53篇内容 | 4089人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1320774, encodeId=c9321320e742d, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=Cardiovasc Diabetol：不同胰岛素抵抗替代指标对2型糖尿病患者经皮冠状动脉介入治疗后预后预测和分层的比较, objectType=article, longId=218500, objectId=c17321850023, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c17321850023, replyNumber=0, likeNumber=180, createdTime=2021-10-14, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c17321850023, moduleTitle=Cardiovasc Diabetol：不同胰岛素抵抗替代指标对2型糖尿病患者经皮冠状动脉介入治疗后预后预测和分层的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c17321850023)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320773, encodeId=660c1320e734c, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=BJH：经皮冠状动脉介入治疗后血小板反应性高的患者的强化抗血小板治疗——抗血栓药物的更佳管理 (OPTIMA)-2试验, objectType=article, longId=218247, objectId=4e9a21824e71, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e9a21824e71, replyNumber=0, likeNumber=136, createdTime=2021-10-10, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e9a21824e71, moduleTitle=BJH：经皮冠状动脉介入治疗后血小板反应性高的患者的强化抗血小板治疗——抗血栓药物的更佳管理 (OPTIMA)-2试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e9a21824e71)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320772, encodeId=53051320e7296, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=Eur Heart J：经皮冠状动脉介入治疗的慢性肾脏病患者替格瑞洛单药治疗效果如何？, objectType=article, longId=216217, objectId=7a6e21621ef1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a6e21621ef1, replyNumber=0, likeNumber=126, createdTime=2021-08-25, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a6e21621ef1, moduleTitle=Eur Heart J：经皮冠状动脉介入治疗的慢性肾脏病患者替格瑞洛单药治疗效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a6e21621ef1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320771, encodeId=ba3a1320e7156, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=Eur Heart J：经皮冠状动脉介入治疗的癌症患者90天内因急性心肌梗塞和出血再入院分析, objectType=article, longId=207919, objectId=222f20e919fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=222f20e919fa, replyNumber=0, likeNumber=136, createdTime=2021-03-07, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=222f20e919fa, moduleTitle=Eur Heart J：经皮冠状动脉介入治疗的癌症患者90天内因急性心肌梗塞和出血再入院分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=222f20e919fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320770, encodeId=6b891320e7033, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=Heart：β受体阻滞剂在经皮冠状动脉介入治疗急性冠脉综合征患者中的作用, objectType=article, longId=200304, objectId=58642003043d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58642003043d, replyNumber=0, likeNumber=127, createdTime=2020-09-07, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58642003043d, moduleTitle=Heart：β受体阻滞剂在经皮冠状动脉介入治疗急性冠脉综合征患者中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58642003043d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320769, encodeId=53711320e69dd, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=Circulation：经皮冠状动脉介入治疗置入药物洗脱支架后的双重抗血小板治疗时间, objectType=article, longId=198826, objectId=d8a019882604, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8a019882604, replyNumber=0, likeNumber=161, createdTime=2020-08-07, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8a019882604, moduleTitle=Circulation：经皮冠状动脉介入治疗置入药物洗脱支架后的双重抗血小板治疗时间, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8a019882604)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320768, encodeId=b0851320e688f, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=Ann Intern Med：经皮冠状动脉介入治疗后房颤双联和三联治疗效果比较, objectType=article, longId=190318, objectId=173719031898, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=173719031898, replyNumber=0, likeNumber=111, createdTime=2020-03-20, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=173719031898, moduleTitle=Ann Intern Med：经皮冠状动脉介入治疗后房颤双联和三联治疗效果比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=173719031898)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320767, encodeId=c1d91320e67a9, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=Heart：经皮冠状动脉介入治疗的急性心肌梗死患者年龄与再入院之间的相关性, objectType=article, longId=189603, objectId=76c5189603c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76c5189603c3, replyNumber=0, likeNumber=147, createdTime=2020-03-11, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76c5189603c3, moduleTitle=Heart：经皮冠状动脉介入治疗的急性心肌梗死患者年龄与再入院之间的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76c5189603c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320766, encodeId=e18d1320e66b8, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=Circulation：Impella在采用机械循环支持的经皮冠状动脉介入治疗患者中的使用、临床预后和费用在近20年来的变化趋势, objectType=article, longId=187112, objectId=2e9d18e11225, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e9d18e11225, replyNumber=0, likeNumber=139, createdTime=2020-02-03, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e9d18e11225, moduleTitle=Circulation：Impella在采用机械循环支持的经皮冠状动脉介入治疗患者中的使用、临床预后和费用在近20年来的变化趋势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e9d18e11225)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320765, encodeId=d3991320e6557, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=Circulation：经皮冠状动脉介入治疗重度主动脉瓣狭窄和冠状动脉疾病, objectType=article, longId=181826, objectId=e7071818261a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7071818261a, replyNumber=0, likeNumber=134, createdTime=2019-10-25, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7071818261a, moduleTitle=Circulation：经皮冠状动脉介入治疗重度主动脉瓣狭窄和冠状动脉疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7071818261a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320764, encodeId=dccb1320e64a2, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=Lancet：三支或左主干病变患者经皮冠状动脉介入治疗与冠状动脉旁路移植术的比较, objectType=article, longId=178759, objectId=d8561e8759a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8561e8759a0, replyNumber=0, likeNumber=101, createdTime=2019-09-05, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8561e8759a0, moduleTitle=Lancet：三支或左主干病变患者经皮冠状动脉介入治疗与冠状动脉旁路移植术的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8561e8759a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320763, encodeId=cf871320e6349, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=JAMA：经皮冠状动脉介入治疗后叶酸，维生素B12和维生素B6同型半胱氨酸降低治疗对临床结果的影响, objectType=article, longId=178308, objectId=4e191e8308a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e191e8308a8, replyNumber=0, likeNumber=77, createdTime=2019-08-30, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e191e8308a8, moduleTitle=JAMA：经皮冠状动脉介入治疗后叶酸，维生素B12和维生素B6同型半胱氨酸降低治疗对临床结果的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e191e8308a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320762, encodeId=02bc1320e626d, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=Clinica Chimica Acta：经皮冠状动脉介入治疗急性ST段抬高性心肌梗死患者术前纤维蛋白原-白蛋白比值对死亡率的影响, objectType=article, longId=177032, objectId=f7671e7032ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7671e7032ba, replyNumber=0, likeNumber=181, createdTime=2019-08-08, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7671e7032ba, moduleTitle=Clinica Chimica Acta：经皮冠状动脉介入治疗急性ST段抬高性心肌梗死患者术前纤维蛋白原-白蛋白比值对死亡率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7671e7032ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320761, encodeId=ae331320e6131, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=Lancet：药物涂层球囊经皮冠状动脉介入治疗可降低出血高危人群的出血风险, objectType=article, longId=175808, objectId=2feb1e5808ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2feb1e5808ec, replyNumber=0, likeNumber=66, createdTime=2019-07-21, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2feb1e5808ec, moduleTitle=Lancet：药物涂层球囊经皮冠状动脉介入治疗可降低出血高危人群的出血风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2feb1e5808ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320760, encodeId=25111320e60da, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=BMJ：药物洗脱支架及经皮冠状动脉介入治疗患者术后应选择短期双抗血小板治疗, objectType=article, longId=174665, objectId=925a1e466513, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=925a1e466513, replyNumber=0, likeNumber=69, createdTime=2019-07-03, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=925a1e466513, moduleTitle=BMJ：药物洗脱支架及经皮冠状动脉介入治疗患者术后应选择短期双抗血小板治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=925a1e466513)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320759, encodeId=f29b1320e5922, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=JCLA：应用药物洗脱支架经皮冠状动脉介入治疗冠心病患者快速血管造影狭窄进展和再狭窄风险的预测因素的综合分析, objectType=article, longId=167632, objectId=935316e63247, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=935316e63247, replyNumber=0, likeNumber=52, createdTime=2019-06-05, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=935316e63247, moduleTitle=JCLA：应用药物洗脱支架经皮冠状动脉介入治疗冠心病患者快速血管造影狭窄进展和再狭窄风险的预测因素的综合分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=935316e63247)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320758, encodeId=83a81320e58bd, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=JAHA：经皮冠状动脉介入治疗后住院死亡率的决定因素, objectType=article, longId=161705, objectId=5df6161e0520, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5df6161e0520, replyNumber=0, likeNumber=79, createdTime=2019-03-07, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5df6161e0520, moduleTitle=JAHA：经皮冠状动脉介入治疗后住院死亡率的决定因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5df6161e0520)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320757, encodeId=478a1320e5782, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=JCLA：急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后血清类风湿因子水平与无再流现象的关系, objectType=article, longId=158377, objectId=856a1583e71f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=856a1583e71f, replyNumber=0, likeNumber=69, createdTime=2019-01-20, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=856a1583e71f, moduleTitle=JCLA：急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后血清类风湿因子水平与无再流现象的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=856a1583e71f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320756, encodeId=575e1320e56d6, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=Eur Heart J：经皮冠状动脉介入治疗前负荷剂量阿托伐他汀对急性冠状动脉综合征患者主要不良心血管事件的短期和长期影响, objectType=article, longId=157375, objectId=a5b115e375e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5b115e375e3, replyNumber=0, likeNumber=80, createdTime=2019-01-07, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5b115e375e3, moduleTitle=Eur Heart J：经皮冠状动脉介入治疗前负荷剂量阿托伐他汀对急性冠状动脉综合征患者主要不良心血管事件的短期和长期影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5b115e375e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320755, encodeId=9c241320e55ca, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=Eur Heart J：癌症患者与经皮冠状动脉介入治疗, objectType=article, longId=154920, objectId=308915492033, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=308915492033, replyNumber=0, likeNumber=88, createdTime=2018-12-03, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=308915492033, moduleTitle=Eur Heart J：癌症患者与经皮冠状动脉介入治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=308915492033)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

经皮冠状动脉介入治疗

2020-05-29

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

Cardiovasc Diabetol：不同胰岛素抵抗替代指标对2型糖尿病患者经皮冠状动脉介入治疗后预后预测和分层的比较

2021-10-14

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

BJH：经皮冠状动脉介入治疗后血小板反应性高的患者的强化抗血小板治疗——抗血栓药物的更佳管理 (OPTIMA)-2试验

2021-10-10

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

Eur Heart J：经皮冠状动脉介入治疗的慢性肾脏病患者替格瑞洛单药治疗效果如何？

2021-08-25

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

Eur Heart J：经皮冠状动脉介入治疗的癌症患者90天内因急性心肌梗塞和出血再入院分析

2021-03-07

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

Heart：β受体阻滞剂在经皮冠状动脉介入治疗急性冠脉综合征患者中的作用

2020-09-07

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

Circulation：经皮冠状动脉介入治疗置入药物洗脱支架后的双重抗血小板治疗时间

2020-08-07

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

Ann Intern Med：经皮冠状动脉介入治疗后房颤双联和三联治疗效果比较

2020-03-20

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

Heart：经皮冠状动脉介入治疗的急性心肌梗死患者年龄与再入院之间的相关性

2020-03-11

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

Circulation：Impella在采用机械循环支持的经皮冠状动脉介入治疗患者中的使用、临床预后和费用在近20年来的变化趋势

2020-02-03

柳叶一刀 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

Circulation：经皮冠状动脉介入治疗重度主动脉瓣狭窄和冠状动脉疾病

2019-10-25

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

Lancet：三支或左主干病变患者经皮冠状动脉介入治疗与冠状动脉旁路移植术的比较

2019-09-05

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

JAMA：经皮冠状动脉介入治疗后叶酸，维生素B12和维生素B6同型半胱氨酸降低治疗对临床结果的影响

2019-08-30

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

Clinica Chimica Acta：经皮冠状动脉介入治疗急性ST段抬高性心肌梗死患者术前纤维蛋白原-白蛋白比值对死亡率的影响

2019-08-08

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

Lancet：药物涂层球囊经皮冠状动脉介入治疗可降低出血高危人群的出血风险

2019-07-21

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

BMJ：药物洗脱支架及经皮冠状动脉介入治疗患者术后应选择短期双抗血小板治疗

2019-07-03

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

JCLA：应用药物洗脱支架经皮冠状动脉介入治疗冠心病患者快速血管造影狭窄进展和再狭窄风险的预测因素的综合分析

2019-06-05

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

JAHA：经皮冠状动脉介入治疗后住院死亡率的决定因素

2019-03-07

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

JCLA：急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后血清类风湿因子水平与无再流现象的关系

2019-01-20

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

Eur Heart J：经皮冠状动脉介入治疗前负荷剂量阿托伐他汀对急性冠状动脉综合征患者主要不良心血管事件的短期和长期影响

2019-01-07

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

Eur Heart J：癌症患者与经皮冠状动脉介入治疗

2018-12-03

科室
- - 订阅+
  - 更多科室
工具
服务